» Articles » PMID: 10664056

Cryopreserved Human Amniotic Membrane for Ocular Surface Reconstruction

Overview
Specialty Ophthalmology
Date 2000 Feb 9
PMID 10664056
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Amniotic membrane transplantation is used for the reconstruction of the ocular surface in the context of, for example, corneal ulcers or conjunctival scarring. The mechanisms by which preserved amniotic membrane grafts promote reepithelialization are unknown. As a first step the viability and proliferative capacity of amnion cells following cryopreservation of membranes in glycerol is investigated.

Methods: Fresh and cryopreserved (in 50% glycerol) amniotic membranes were investigated histologically and by vital stains. Following enzymatic digestion, amniotic cells were stained for viability and cultured in DMEM+10% FBS. In addition, explant cultures were established from fresh and cryopreserved membranes.

Results: Histological examination showed no significant morphological alteration following cryopreservation. While fresh membranes contained predominantly vital cells, no such cells were detected following cryopreservation. Also, cells removed enzymatically from cryopreserved membranes were not viable and did not grow in culture. While both epithelial and fibroblastic cells grew from fresh membranes, no growth was seen from cryopreserved membranes.

Conclusion: The results suggest that the technique for preservation which is most widely used for ophthalmological amniotic membrane transplantation significantly impairs viability and proliferative capacity. This supports the clinical finding that neither immunological reactions nor signs of ingrowth of amniotic cells are observed in patients. Furthermore amniotic membrane grafts seem to function primarily as matrix and not by virtue of transplanted functional cells.

Citing Articles

Introduction to Amniotic Membranes in Maxillofacial Surgery-A Scoping Review.

Dawiec G, Niemczyk W, Wiench R, Niemczyk S, Skaba D Medicina (Kaunas). 2024; 60(4).

PMID: 38674309 PMC: 11051762. DOI: 10.3390/medicina60040663.


Self-Retained, Sutureless Amniotic Membrane Transplantation for the Management of Ocular Surface Diseases.

Chiu H, Tsai C J Clin Med. 2023; 12(19).

PMID: 37834866 PMC: 10573988. DOI: 10.3390/jcm12196222.


Placental-Derived Biomaterials and Their Application to Wound Healing: A Review.

Protzman N, Mao Y, Long D, Sivalenka R, Gosiewska A, Hariri R Bioengineering (Basel). 2023; 10(7).

PMID: 37508856 PMC: 10376312. DOI: 10.3390/bioengineering10070829.


An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study.

Mao Y, Protzman N, John N, Kuehn A, Long D, Sivalenka R J Biomed Mater Res B Appl Biomater. 2022; 111(3):684-700.

PMID: 36370413 PMC: 10099462. DOI: 10.1002/jbm.b.35186.


The Use of Quercetin to Improve the Antioxidant and Regenerative Properties of Frozen or Cryopreserved Human Amniotic Membrane.

Purpura V, Benedetti S, Bondioli E, Scarpellini F, Giacometti A, Albertini M Antioxidants (Basel). 2022; 11(7).

PMID: 35883741 PMC: 9311548. DOI: 10.3390/antiox11071250.